UBS O'Connor’s MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share MDH.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding MDH.WS
MP
RCM
BFM
PF
AC
KC
OCAM
BCM
UBS O'Connor's MDH.WS Position: Q1 2022 in Review
UBS O'Connor sold out of MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (MDH.WS) in Q1 2022, closing a stake of 154,128 shares — an estimated $71K sold.
UBS O'Connor first reported a position in MDH.WS in Q2 2021 and held it in 3 quarters. The position peaked at $116K in Q2 2021. 52 funds tracked by Wall St. Rank hold MDH.WS as of Q1 2022.
- UBS O'Connor reported no remaining MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q1 2022 after selling out during the quarter.
- UBS O'Connor sold 154,128 MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q1 2022, an estimated $71K.
- UBS O'Connor first reported a position in MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 3 quarters.
- UBS O'Connor's MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $116K in Q2 2021.
- 52 funds tracked by Wall St. Rank held MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q1 2022.
Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.